On the other hand, Liu et al. described PABPC4 expression as favorable to patient survival that presented with colorectal cancer [77], whereas the data derived from the Human Protein Atlas indicated that unfavorable outcomes are associated with PABPC4 expression in both renal cancer and liver cancer [78]. This evidence concerns the gene PABPC4 and liver cancer.